Losartan to Reverse Sickle Nephropathy

Clinical trial NCT01479439 · COMPLETED

Trial details

NCT number: NCT01479439
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nephropathy Sickle Cell Anemia

Start date: 2012-02-01
Primary completion: 2015-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.